Pharmacological management of progressive-fibrosing interstitial lung diseases: a review of the current evidence
A proportion of patients with interstitial lung diseases (ILDs) are at risk of developing a progressive-fibrosing phenotype, which is associated with a deterioration in lung function and early mortality. In addition to idiopathic pulmonary fibrosis (IPF), fibrosing ILDs that may present a progressiv...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Respiratory Society
2018-12-01
|
| Series: | European Respiratory Review |
| Online Access: | http://err.ersjournals.com/content/27/150/180074.full |